Transoceanic Travelers Need to Correct Insulin Timing
By HospiMedica International staff writers Posted on 09 Jun 2016 |

Image: New research suggests air travel across multiple time zones may require adjustment of diabetes medications (Photo courtesy of the University of Texas Medical Branch).
Air travel passengers crossing multiple time zones may have to adjust their insulin dose to protect themselves against episodes of hypoglycemia, according to a new study.
Researchers at the University of Texas Medical Branch (UTMB, Galveston, USA) conducted a review of PUBMED and MEDLINE databases for articles that discussed air travel and diabetes. In all, 99 peer-reviewed articles and two diabetic nursing guidelines were identified. The researchers found that about 2% of airline related diversions due to medical emergencies are due to diabetes complications, and that 10% of diabetics who travel will have a problem.
The researchers also made several recommendations. First, they stated that for short/rapid-acting insulin, no dose adjustment was needed. During eastward travel, intermediate/long-acting insulin should be reduced in dose proportional to hours lost. During westward travel, correction scale insulin with rapid acting insulin can be used, or the dose to be administered during travel can be given as divided doses to span the longer travel day.
They also discouraged the use of pre-mixed insulin, due to difficulty in titrating effects, and added that insulin pumps could be used per usual basal bolus dosing; however, cabin depressurization may lead to unintended bolus dosing, increasing the risk of hypoglycemia. The study was presented at the annual meeting of the American Association of Clinical Endocrinologists, held during May 2016 in Orlando (FL, USA).
“When people travel and are not attentive to their insulin intake they can either overdose or underdose their insulin. It can happen because they are taking their regular amount of insulin but not eating enough, or they are taking their insulin too early, usually if a person is traveling east across multiple time zones,” said study presenter Rahul Suresh, MD. “When traveling west, there may be gaps in diabetic complications causing hyperglycemia, which is important among patients diagnosed with type 1 diabetes.”
“When flying from the U.S. to Europe, for example, a person would be in danger of taking too much basal insulin due to a 6-hour time change, so they need to adjust their daily dose in the U.S. to 75% of normal,” added Dr. Suresh. “Therefore, when they take the full dose in Europe they haven't taken too much insulin. Similarly, when going west, patients with diabetes and on insulin may have to increase their dosages because the day can be longer.”
Related Links:
University of Texas Medical Branch
Researchers at the University of Texas Medical Branch (UTMB, Galveston, USA) conducted a review of PUBMED and MEDLINE databases for articles that discussed air travel and diabetes. In all, 99 peer-reviewed articles and two diabetic nursing guidelines were identified. The researchers found that about 2% of airline related diversions due to medical emergencies are due to diabetes complications, and that 10% of diabetics who travel will have a problem.
The researchers also made several recommendations. First, they stated that for short/rapid-acting insulin, no dose adjustment was needed. During eastward travel, intermediate/long-acting insulin should be reduced in dose proportional to hours lost. During westward travel, correction scale insulin with rapid acting insulin can be used, or the dose to be administered during travel can be given as divided doses to span the longer travel day.
They also discouraged the use of pre-mixed insulin, due to difficulty in titrating effects, and added that insulin pumps could be used per usual basal bolus dosing; however, cabin depressurization may lead to unintended bolus dosing, increasing the risk of hypoglycemia. The study was presented at the annual meeting of the American Association of Clinical Endocrinologists, held during May 2016 in Orlando (FL, USA).
“When people travel and are not attentive to their insulin intake they can either overdose or underdose their insulin. It can happen because they are taking their regular amount of insulin but not eating enough, or they are taking their insulin too early, usually if a person is traveling east across multiple time zones,” said study presenter Rahul Suresh, MD. “When traveling west, there may be gaps in diabetic complications causing hyperglycemia, which is important among patients diagnosed with type 1 diabetes.”
“When flying from the U.S. to Europe, for example, a person would be in danger of taking too much basal insulin due to a 6-hour time change, so they need to adjust their daily dose in the U.S. to 75% of normal,” added Dr. Suresh. “Therefore, when they take the full dose in Europe they haven't taken too much insulin. Similarly, when going west, patients with diabetes and on insulin may have to increase their dosages because the day can be longer.”
Related Links:
University of Texas Medical Branch
Latest Critical Care News
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
- Noninvasive Double Microbubble Delivery Approach Marks Breakthrough in Brain Cancer Treatment
- Self-Healing Skin-Like Material to Find Applications in Health Monitoring, Surgery and Implants
- Highly-Sensitive Electronic Skin Allows Robots to Feel Heat, Pain and Pressure
- AI-Powered Wearable Sensor Predicts Labor Onset in Pregnant Women
Channels
Surgical Techniques
view channel
Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
Aneurysms, especially when located in the brain, can be life-threatening if not treated effectively. Intracranial aneurysms, caused by the dilation of blood vessels due to weaknesses in the vessel wall,... Read more
New Surgical Technique Safely Removes Giant Nerve Tumors
Giant plexiform neurofibromas (PNF) are benign tumors commonly associated with neurofibromatosis Type 1 (NF1), a genetic disorder affecting approximately 1 in 3,000 live births. These tumors, which occur... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more